CSL set to invest $313m to bulk up flu, COVID-19 mRNA tech
MELBOURNE: Blood products giant CSL is investing at least $US200 million ($313 million) to beef
MELBOURNE: Blood products giant CSL is investing at least $US200 million ($313 million) to beef
FEATURED
Digital tools boost dementia care for homebound patients
Developer proposes turning empty offices into seniors housing
Architects designs stepped senior housing to “balance togetherness with independence”
Tropical oasis offers sanctuary from the troubles of ageing
Affordable housing group open 81-unit seniors housing community
Assisted living providers learn strategies to tackle staffing challenges
INNOVATION
